Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

2.

Consumer access to clozapine in Australia: how does this compare to New Zealand and the United Kingdom?

Knowles SA, Mcmillan SS, Wheeler AJ.

Pharm Pract (Granada). 2016 Apr-Jun;14(2):722. doi: 10.18549/PharmPract.2016.02.722. Epub 2016 Jun 15.

4.

Lay health supporters aided by a mobile phone messaging system to improve care of villagers with schizophrenia in Liuyang, China: protocol for a randomised control trial.

Xu DR, Gong W, Caine ED, Xiao S, Hughes JP, Ng M, Simoni J, He H, Smith KL, Brown HS 3rd, Gloyd S.

BMJ Open. 2016 Jan 20;6(1):e010120. doi: 10.1136/bmjopen-2015-010120.

5.

The Promises and Challenges of Ecological Momentary Assessment in Schizophrenia: Development of an Initial Experimental Protocol.

Gaudiano BA, Moitra E, Ellenberg S, Armey MF.

Healthcare (Basel). 2015 Sep;3(3):556-73. doi: 10.3390/healthcare3030556. Epub 2015 Jul 15.

6.

Using the theory of planned behavior to improve treatment adherence in Mexican Americans with schizophrenia.

Kopelowicz A, Zarate R, Wallace CJ, Liberman RP, Lopez SR, Mintz J.

J Consult Clin Psychol. 2015 Oct;83(5):985-93. doi: 10.1037/a0039346. Epub 2015 Jun 1.

7.

Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia.

Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A.

PLoS One. 2015 Mar 27;10(3):e0120560. doi: 10.1371/journal.pone.0120560. eCollection 2015.

8.

Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Drake RJ, Nordentoft M, Haddock G, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leucht S, Leweke M, McGuire P, Meyer-Lindenberg A, Rujescu D, Sommer IE, Kahn RS, Lewis SW.

Schizophr Bull. 2015 May;41(3):584-96. doi: 10.1093/schbul/sbv015. Epub 2015 Mar 5.

9.

Perspectives on reasons of medication nonadherence in psychiatric patients.

Mert DG, Turgut NH, Kelleci M, Semiz M.

Patient Prefer Adherence. 2015 Jan 13;9:87-93. doi: 10.2147/PPA.S75013. eCollection 2015.

10.

Compliance as a stable function in the treatment course of bipolar disorder in patients stabilized on olanzapine: results from a 24-month observational study.

Kutzelnigg A, Kopeinig M, Chen CK, Fábián A, Pujol-Luna MG, Shin YC, Treuer T, D'yachkova Y, Deix C, Kasper S, Doby D.

Int J Bipolar Disord. 2014 Oct 23;2(1):13. doi: 10.1186/s40345-014-0013-x. eCollection 2014 Dec.

11.

Quantitative levels of aripiprazole parent drug and metabolites in urine.

McEvoy J, Millet RA, Dretchen K, Morris AA, Corwin MJ, Buckley P.

Psychopharmacology (Berl). 2014 Dec;231(23):4421-8. doi: 10.1007/s00213-014-3781-1. Epub 2014 Oct 28.

12.

Prevalence and Correlates of Missed First Appointments among Outpatients at a Psychiatric Hospital in Nigeria.

Akhigbe S, Morakinyo O, Lawani A, James B, Omoaregba J.

Ann Med Health Sci Res. 2014 Sep;4(5):763-8. doi: 10.4103/2141-9248.141550.

13.

The economics of medicines optimization: policy developments, remaining challenges and research priorities.

Faria R, Barbieri M, Light K, Elliott RA, Sculpher M.

Br Med Bull. 2014 Sep;111(1):45-61. doi: 10.1093/bmb/ldu021. Review.

14.

Tackling nonadherence in psychiatric disorders: current opinion.

Farooq S, Naeem F.

Neuropsychiatr Dis Treat. 2014 Jun 12;10:1069-77. doi: 10.2147/NDT.S40777. eCollection 2014. Review.

15.
16.

Efficacy of shared decision making on treatment satisfaction for patients with first-admission schizophrenia: study protocol for a randomised controlled trial.

Ishii M, Okumura Y, Sugiyama N, Hasegawa H, Noda T, Hirayasu Y, Ito H.

BMC Psychiatry. 2014 Apr 14;14:111. doi: 10.1186/1471-244X-14-111.

17.

Explaining attitudes and adherence to antipsychotic medication: the development of a process model.

Wiesjahn M, Jung E, Lamster F, Rief W, Lincoln TM.

Schizophr Res Treatment. 2014;2014:341545. doi: 10.1155/2014/341545. Epub 2014 Feb 19.

18.

Prospective trial of customized adherence enhancement plus long-acting injectable antipsychotic medication in homeless or recently homeless individuals with schizophrenia or schizoaffective disorder.

Sajatovic M, Levin J, Ramirez LF, Hahn DY, Tatsuoka C, Bialko CS, Cassidy KA, Fuentes-Casiano E, Williams TD.

J Clin Psychiatry. 2013 Dec;74(12):1249-55. doi: 10.4088/JCP.12m08331.

19.

The impact of a pharmacist assisted clinic upon medication adherence and quality of life in mental health patients.

Lizer MH, Parnapy Jawaid SA, Marsh W, Mogili L.

Pharm Pract (Granada). 2011 Jul;9(3):122-7. Epub 2011 Sep 14.

20.

Medication non-adherence among adult psychiatric out patients in Jimma University Specialized Hospital, Southwest Ethiopia.

Tesfay K, Girma E, Negash A, Tesfaye M, Dehning S.

Ethiop J Health Sci. 2013 Nov;23(3):227-36.

Supplemental Content

Support Center